KARKINOX Trademark

Trademark Overview

On Friday, September 23, 2022, a trademark application was filed for KARKINOX with the United States Patent and Trademark Office. The USPTO has given the KARKINOX trademark a serial number of 97604786. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, May 15, 2026. This trademark is owned by KarkinoX Pharma, Inc.. The KARKINOX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of oncology; pharmaceutical research and development
karkinox

General Information

Serial Number97604786
Word MarkKARKINOX
Filing DateFriday, September 23, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, May 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesMedical and scientific research in the field of oncology; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKarkinoX Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMilpitas, CA 95035
US
Party NameKarkinoX Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMilpitas, CA 95035
US

Trademark Events

Event DateEvent Description
Tuesday, September 27, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 6, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 11, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 19, 2023ASSIGNED TO LIE
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024SOU EXTENSION 1 FILED
Monday, October 28, 2024SOU EXTENSION 1 GRANTED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 28, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 28, 2025SOU EXTENSION 2 FILED
Wednesday, May 28, 2025SOU EXTENSION 2 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 18, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, November 18, 2025SOU EXTENSION 3 FILED
Tuesday, November 18, 2025SOU EXTENSION 3 GRANTED
Wednesday, November 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 14, 2026SOU TEAS EXTENSION RECEIVED
Thursday, May 14, 2026SOU EXTENSION 4 FILED
Friday, May 15, 2026SOU EXTENSION 4 GRANTED
Sunday, May 17, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

karkinox research pharmaceutical development oncology field scientific medical